Journal Report

ONCOLOGY LETTERS

Download PDF
Journal Information
Journal Title
ONCOLOGY LETTERS
Publisher
SPANDIDOS PUBL LTD
ISSN
1792-1074
E-ISSN
1792-1082
Database
Clarivate
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
[Expression of Concern] Geldanamycin induces apoptosis in human gastric carcinomas by affecting multiple oncogenic kinases that have synergic effects with TNF‑related apoptosis‑inducing ligand
Hui Chen, Liang-Qing Li, Dun Pan
2026-11-11 Vol. 33 Issue 1 Pages 1-1
DOI: 10.3892/ol.2026.15946
Metastatic tumor burden and the modified Glasgow Prognostic Score are independent prognostic factors in metastatic triple‑negative breast cancer: A multicenter real‑world study
Erkut Demirciler, Elif Atağ, Eda Yildirim et al.
2026-11-11 Vol. 33 Issue 1 Pages 1-9
DOI: 10.3892/ol.2026.15947
Fruit seed extracts: A class of natural anticancer candidate resources (Review)
Jing Tang, Chang Xu, Jingkui Tian et al.
2026-11-10 Vol. 33 Issue 1 Pages 1-13
DOI: 10.3892/ol.2026.15943
Site‑specific timing and mode of detection of locoregional recurrence after breast cancer surgery
Kazunoshin Tachibana, Masaru Noda, Nobuhiro Hoshi et al.
2026-11-10 Vol. 33 Issue 1 Pages 1-7
DOI: 10.3892/ol.2026.15944
Oncogenic mechanisms and therapeutic potential of SALL4 in hematological malignancies (Review)
Qiuyue Wu, Wenhui Liu, Yang Liu et al.
2026-11-10 Vol. 33 Issue 1 Pages 1-12
DOI: 10.3892/ol.2026.15942
Immunohistochemistry‑quantified EGFR mutant protein expression percentage outperforms next‑generation sequencing‑derived mutational abundance for predicting tyrosine kinase inhibitor efficacy in non‑small cell lung cancer
Boxuan Xiang, Qi Zhou, Rongrong Xie
2026-11-10 Vol. 33 Issue 1 Pages 1-11
DOI: 10.3892/ol.2026.15945
[Retracted] Bone morphogenetic protein and activin membrane‑bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF‑β‑induced EMT signaling pathway
Fengsong Liu, Kai Wang, Liang Zhang et al.
2026-11-9 Vol. 33 Issue 1 Pages 1-1
DOI: 10.3892/ol.2026.15941
Feasibility of a targeted protein panel for personalized treatment in advanced adenoid cystic carcinoma: A proof‑of‑concept study 
Rubens Thölken, Adrian Von Witzleben, Simon Laban et al.
2026-11-6 Vol. 33 Issue 1 Pages 1-8
DOI: 10.3892/ol.2026.15939
Residual gastric cancer risk after <i>Helicobacter pylori</i> eradication: Mucosal immune trajectories (Review)
Jian Chen, Bolin Tang, Li Zhou
2026-11-6 Vol. 33 Issue 1 Pages 1-15
DOI: 10.3892/ol.2026.15940
Progress in anticancer chemical constituents and pharmacological research of <i>Carpesium cernuum</i> L. (Review)
Jingxin Mao, Yang Liu, Mengqian Li et al.
2026-11-4 Vol. 33 Issue 1 Pages 1-30
DOI: 10.3892/ol.2026.15938
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 15, 2026 02:42